IFN-γ is a therapeutic agent with multiple immunomodulatory, antiviral, antimicrobial, antitumor, and proinflammatory activities; it is primarily involved in host defense against infections and tumor surveillance, and plays a critical role in inhibiting tumor development and progression by stimulating the immune system (49). The gene discussed is IFNG; the disease is neoplasm.